Announcements

6 May 2026
Head and Neck Cancer Awareness Month, April 2026

As part of its continued efforts to support impactful cancer research and foster scientific dialogue, MDPI is spotlighting head and neck cancer in this edition. Encompassing a diverse group of malignancies affecting the oral cavity, pharynx, and larynx, head and neck cancers collectively account for over 900,000 new cases and more than 400,000 deaths globally each year.

In recent years, shifting epidemiological patterns, particularly the rise of HPV-associated cancers, have introduced new challenges and opportunities in both research and clinical practice. These developments call for deeper insights into disease mechanisms, as well as more precise approaches to diagnosis, treatment, and patient stratification.

By bringing together cutting-edge research, focused Special Issues, and an expert-led webinar, MDPI journals aim to continue to facilitate knowledge exchange and highlight emerging advances in the field. These efforts play an important role in advancing innovation, improving early detection and therapeutic strategies, and ultimately enhancing outcomes for patients worldwide.

Keynote speakers

圆形图片 圆形图片 圆形图片

Dr. Kousik Kumar Kesh,
St. Louis University, USA

Prof. Dr. Richard Yuxiong Su,
The University of Hong Kong, Hong Kong S.A.R

Dr. Jennifer Anderson,
The University of Texas, USA

圆形图片 圆形图片 圆形图片

Dr. Jay J. Liao,
University of Washington Medical Center, USA

Prof. Dr. Wendell G. Yarbrough,
University of North Carolina, USA

Dr. Joshua D. Smith,
University of Pittsburgh Medical Center, USA

Register for this webinar for free here!

Enhancing Patient Outcomes in Head and Neck Cancer Radiotherapy: Integration of Electronic Patient-Reported Outcomes and Artificial Intelligence-Driven Oncology Care Using Large Language Models
by ChihYing Liao, ChinNan Chu, TingChun Lin, TzuYao Chou and MengHsiun Tsai
Cancers 2025, 17(14), 2345; https://doi.org/10.3390/cancers17142345

Advancing Head and Neck Cancer Therapies: From Conventional Treatments to Emerging Strategies
by Aleksandra Mordzińska-Rak, Ilona Telejko, Grzegorz Adamczuk, Tomasz Trombik, Andrzej Stepulak and Ewa Błaszczak
Biomedicines 2025, 13(5), 1046; https://doi.org/10.3390/biomedicines13051046

The Role of Dysphagia on Head and Neck Cancer Patients’ Quality of Life, Functional Disabilities and Psychological Distress: Outcomes of Cancer Rehabilitation from an Observational Single-Center Study
by Špela Matko, Christina Knauseder, David Riedl, Vincent Grote, Michael J. Fischer, Samuel Moritz Vorbach, Karin Pfaller-Frank, Wilhelm Frank and Thomas Licht
Curr. Oncol. 2025, 32(4), 220; https://doi.org/10.3390/curroncol32040220

PDLIM3 Regulates Migration and Invasion of Head and Neck Squamous Cell Carcinoma via YAP–Mediated Epithelial–Mesenchymal Transition
by Fan Yang, Ying Zhou, You Zhang, Weideng Wei, Fei Huang, Dan Yang, Yixin Zhang, Ruiyang Zhang, Xiaoqiang Xia, Qianming Chen et al.
Int. J. Mol. Sci. 2025, 26(7), 3147; https://doi.org/10.3390/ijms26073147

Inflammatory Biomarkers and Oral Health Disorders as Predictors of Head and Neck Cancer: A Retrospective Longitudinal Study
by Amr Sayed Ghanem, Kitti Sipos, Ágnes Tóth and Attila Csaba Nagy
Int. J. Mol. Sci. 2025, 26(5), 2279; https://doi.org/10.3390/ijms26052279

Trends in Incidence and Mortality of Head and Neck Cancer Subsites Among Elderly Patients: A Population-Based Analysis
by Małgorzata Wierzbicka, Wioletta Pietruszewska, Adam Maciejczyk and Jarosław Markowski
Cancers 2025, 17(3), 548; https://doi.org/10.3390/cancers17030548

Recurrent and Metastatic Head and Neck Cancer: Mechanisms of Treatment Failure, Treatment Paradigms, and New Horizons
by William T. Barham, Marshall Patrick Stagg, Rula Mualla, Michael DiLeo and Sagar Kansara
Cancers 2025, 17(1), 144; https://doi.org/10.3390/cancers17010144

Identification of Biomarkers for Diagnosis and Prognosis of Head and Neck Cancer: Bioinformatics Approach
by Alexandra Fernandes and Rui Vitorino
Targets 2024, 2(4), 470-480; https://doi.org/10.3390/targets2040026

Clinical Evidence of Methods and Timing of Proper Follow-Up for Head and Neck Cancers
by Riccardo Gili, Simone Caprioli, Paola Lovino Camerino, Gianluca Sacco, Tommaso Ruelle, Daria Maria Filippini, Silvia Pamparino, Stefania Vecchio, Filippo Marchi, Lucia Del Mastro et al.
Onco 2024, 4(4), 275-286; https://doi.org/10.3390/onco4040020

Artificial Intelligence in Head and Neck Cancer: Innovations, Applications, and Future Directions
by Tuan D. Pham, Muy-Teck Teh, Domniki Chatzopoulou, Simon Holmes and Paul Coulthard
Curr. Oncol. 2024, 31(9), 5255-5290; https://doi.org/10.3390/curroncol31090389

The Advances in Proton Therapy in Head-and-Neck Cancers
Guest Editors: Dr. Nancy Lee and Dr. Edward Christopher Dee
Deadline for manuscript submissions: 31 May 2026

Decoding and Remodeling the Suppressive Tumor Immune Microenvironment in Head and Neck Cancer
Guest Editors: Dr. Andrew G. Sikora and Dr. Jennifer L. Anderson
Deadline for manuscript submissions: 20 June 2026

The Role of Targeted Therapy in Head and Neck Cancers
Guest Editor: Dr. Rikki A.M. Brown
Deadline for manuscript submissions: 30 June 2026

Molecular Targets for HPV-Related Head and Neck Cancer
Guest Editor: Dr. Joshua D. Smith
Deadline for manuscript submissions: 31 October 2026

Head and Neck Cancer: From Mechanisms to Therapeutic Approaches—Advances and Challenges
Guest Editors: Dr. Barbara Verro, Dr. Carmelo Saraniti and Dr. Daniela Carlisi
Deadline for manuscript submissions: 31 October 2026

Targeting Head and Neck Cancer: From Tumor Microenvironment to Therapy Resistance
Guest Editors: Prof. Dr. Ratna B. Ray and Dr. Subhayan Sur
Deadline for manuscript submissions: 15 November 2026

       

More News...
Back to TopTop